A Contrastive Pragmatic Study of Offer in English and Arabic
International Academic Journal of Education and Literature · 10.11.2022 · 03 (02) · 1-3
DOI: 10.47310/iarjel.2022.v03i02.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Academic Journal of Education and Literature, online erschienen am 10.11.2022. Verfasst von Zina Abdul-Hussein Khudhair Ashammari und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The current paper deals with offer as a speech act in both English and Arabic. It aims at finding out the basic pragmatic components of speech acts underlying the structure of offer used in English and Arabic. It also aims at explicating the pragmatic strategies of offer in English and Arabic. To achieve the aims of the study, it is hypothesized that: Speech acts are the basic pragmatic components underlying the structure of offer used in English and Arabic. Indirectness is the most common pragmatic strategy used to express offer in English and Arabic. Accordingly, the steps adopted to fulfill the aims of the study are as follows: 1. Conducting a survey of the literature written about offer in English and Arabic. 2. Presenting a theoretical part that analyses the speech act of offer in English and Arabic.
Zitieren
APA
Ashammari, Z. A. K., & Jubran, H. S. Y. (2022). A Contrastive Pragmatic Study of Offer in English and Arabic. International Academic Journal of Education and Literature, 03(02), 1-3. https://doi.org/10.47310/iarjel.2022.v03i02.011
Vancouver
Ashammari ZAK, Jubran HSY. A Contrastive Pragmatic Study of Offer in English and Arabic. International Academic Journal of Education and Literature. 2022;03(02):1-3. doi:10.47310/iarjel.2022.v03i02.011
BibTeX
@article{Ashammari2022,
author = {Ashammari, Zina Abdul-Hussein Khudhair and Jubran, Haider Saad Yahya},
title = {A Contrastive Pragmatic Study of Offer in English and Arabic},
journal = {International Academic Journal of Education and Literature},
year = {2022},
volume = {03},
number = {02},
pages = {1--3},
doi = {10.47310/iarjel.2022.v03i02.011}
}
EUVIMED